Skip to main navigation
Skip to search
Skip to main content
Mayo Clinic Home
Home
Profiles
Departments/Divisions
Grants
Research output
Prizes
Search by expertise, name or affiliation
Pharmacokinetic interactions of antidepressants
Elliott Richelson
Neuroscience
Research output
:
Contribution to journal
›
Review article
›
peer-review
29
Scopus citations
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Pharmacokinetic interactions of antidepressants'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Medicine & Life Sciences
Cytochrome P-450 Enzyme System
100%
Antidepressive Agents
92%
Pharmacokinetics
77%
Serotonin Uptake Inhibitors
56%
nefazodone
41%
Cytochrome P-450 Enzyme Inhibitors
40%
Mirtazapine
36%
Fluvoxamine
35%
Serotonin and Noradrenaline Reuptake Inhibitors
35%
Venlafaxine Hydrochloride
34%
Sertraline
33%
Cytochrome P-450 CYP1A2
33%
Serotonin Antagonists
32%
Paroxetine
32%
Cytochrome P-450 CYP2D6
32%
Fluoxetine
29%
Cytochrome P-450 CYP3A
29%
Obsessive-Compulsive Disorder
28%
Isoenzymes
25%
Pharmaceutical Preparations
21%
Elderly
17%
Liver
13%